Histidine 225, a Residue of the NhaA-Na+/H+ Antiporter of Escherichia coli Is Exposed and Faces the Cell Exterior*

(Received for publication, May 9, 1996, and in revised form, October 30, 1996)

Y. Olami Dagger , A. Rimon , Y. Gerchman , A. Rothman § and E. Padan

From the Division of Microbial and Molecular Ecology, The Hebrew University of Jerusalem, 91904 Jerusalem, Israel

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Cysteine residues were found nonessential in the mechanism of the NhaA antiporter activity of Escherichia coli. The functional C-less NhaA has provided the groundwork to study further histidine 225 of NhaA which has previously been suggested to play an important role in the activation of NhaA at alkaline pH (Rimon, A., Gerchman, Y., Olami, Y., Schuldiner, S. and Padan, E. (1995) J. Biol. Chem. 270, 26813-26817). C-less H225C was constructed and shown to possess an antiporter activity 60% of that of C-less antiporter and a pH profile similar to that of both the C-less or wild-type antiporters. Remarkably, whereas neither the wild-type nor the C-less antiporters were affected by N-ethylmaleimide, C-less H225C was inhibited by this reagent. To determine the degree of alkylation of the antiporter protein by N-ethylmaleimide, antiporter derivatives tagged at their C termini with six histidines residues were constructed. Alkylation of C-less H225C was measured by labeling of everted membrane vesicles with [14C]N-ethylmaleimide, affinity purification of the His-tagged antiporter, and determination of the radioactivity of the purified protein. This assay showed that H225C is alkylated to a much higher level than any of the native cysteinyl residues of NhaA reaching saturation at alkyl/NhaA stoichiometry of 1. The wild-type derivative showed at least 10-fold less alkylation even at higher concentrations, suggesting that H225C resides in a domain that is much more exposed to N-ethylmaleimide than the native cysteinyl residues of NhaA.

Since H225C residues both in right-side out and inside-out membrane vesicles were quantitatively alkylated by N-ethylmaleimide, this assay was used to determine the accessibility of H225C to other SH reagents by titrating the H225C left free to react with N-ethylmaleimide, following exposure of the membranes to the reagents. Furthermore, since membrane-impermeant probes can react with residues in membrane-embedded protein only if accessible to the medium containing the reagent, the assay was used to determine the membrane topology of H225C.

As expected for a membrane-permeant probe, p-chloromercuribenzoate reacted with H225C as efficiently as N-ethylmaleimide in both membrane orientations. Similar results were obtained with methanethiosulfonate ethylammonium supporting the recent observations that this probe is membrane-permeant. On the other hand, both membrane-impermeant reagents p-chloromercuribenzosulfonate and methanethiosulfonate ethyl-trimethyl ammonium bromide reacted with H225C 10-fold more in right-side out than in inside-out vesicles, and p-chloromercuribenzosulfonate also blocked completely the H225C in intact cells. These results strongly suggest that H225C is exposed at the periplasmic face of the membrane.


INTRODUCTION

Sodium proton antiporters are ubiquitous membrane proteins found in the cytoplasmic and organelle membranes of cells of many different origins, including plants, animals, and microorganisms. They are involved in cell energetics and play primary roles in the regulation of intracellular pH, cellular Na+ content, and cell volume (reviewed in Refs. 1-4).

Escherichia coli has two antiporters, NhaA (5) and NhaB (6), that specifically exchange Na+ or Li+ for H+ (4). nhaA is indispensable for adaptation to high salinity, for challenging Li+ toxicity, and for growth at alkaline pH (in the presence of Na+) (7). Accordingly, expression of nhaA which is dependent on NhaR, a positive regulator, is induced by Na+ in a pH-dependent manner (8-10). nhaB by itself confers a limited sodium tolerance to the cells but becomes essential when the lack of NhaA activity limits growth (11).

Both the NhaA and NhaB are electrogenic antiporters that have been purified to homogeneity and reconstituted in a functional form in proteoliposomes (12-14). With the purified antiporters it was found that the H+/Na+ stoichiometry of NhaA is 2H+/Na+ and that of NhaB is 3H+/2Na+; NhaB but not NhaA is sensitive to amiloride derivatives, and the rate of NhaA but not of NhaB is drastically dependent on pH, changing its Vmax over 3 orders of magnitude from pH 7 to pH 8 (12).

None of the eight histidines of NhaA were found essential for the Na+/H+ antiporter activity of NhaA (15). However, replacement of histidine 225 (His-225, previously mistakenly numbered His-226) by Arg (H225R) suggested that His-225 has an important role in the pH sensitivity of the antiporter (15). Whereas the activation of the wild-type NhaA occurs between pH 7.5 and pH 8, that of H225R antiporter occurs between pH 6.5 and pH 7.5. In addition, while the wild-type antiporter remains almost fully active, at least up to pH 8.5, H225R is reversibly inactivated above pH 7.5, retaining only 10-20% of the maximal activity at pH 8.5 (15). Furthermore, we have recently shown that replacement of His-225 with either cysteine (H225C) or serine (H225S) but not alanine (H225A) yielded an antiporter with a wild-type pH-sensitive phenotype, implying that polarity and/or hydrogen bonding, the common properties shared by His, Cys, and Ser, are essential at position 225 for pH regulation of NhaA (16).

In the present work we found that the three cysteine residues of NhaA are not essential in the mechanism of the antiporter, confirming previous findings on the lack of inhibition by SH reagents (17). The functional antiporter devoid of cysteinyl residues has provided the basis to design mutants of NhaA in which a suggested important residue such as His-225 is replaced with cysteinyl residue which can then be reacted specifically with sulfhydryl reagents. Analysis of these site-directed chemical modifications can bear upon both the importance as well as the topology of the original residue (Cys scanning). For this purpose, C-less H225C was constructed and shown to possess an antiporter activity 60% of that of C-less antiporter and a pH profile similar to that of both the C-less or wild-type antiporters. Remarkably, whereas neither the wild-type nor the C-less antiporters were affected by NEM,1 C-less H225C was inhibited by this reagent. Furthermore, H225C was alkylated to a much higher level than any of the native cysteinyl residues of NhaA suggesting that H225C resides in the protein in a domain which is much more exposed to NEM than the native cysteinyl residues of NhaA. However, since NEM is membrane-permeable, it was impossible to deduce from these experiments the membrane topology of H225C with respect to neither the periplasmic nor the cytoplasmic face of the membrane.

Various SH reagents have been suggested to be membrane-impermeant and react only with residues exposed to the medium containing the reagents. Thus periplasmic exposed residues are expected to be affected only in intact cells or RSO membrane vesicles and cytoplasmic facing residues only in ISO membrane vesicles. On the other hand, membrane-permeant reagents are expected to react irrespective of the membrane orientation. On the basis of these differences various SH reagents were exploited to assay the cross-membrane topology of native or strategically placed Cys residues in membrane-embedded proteins. This approach was of value to the structural work of bacteriorhodopsin (18). A similar approach is now being used to probe functional regions with many membrane proteins including the acetylcholine receptor ion channel (19, 20) as well as LacY, the H+/lactose symporter (21), and UhpT, the anion exchange protein (22) both in E. coli.

In the present work, we have used the same approach to probe the reactivity of C-less H225C to various SH reagents, both in intact cells as well as in membrane vesicles of known orientation. The differential reactivity of the membrane-impermeant reagents with C-less H225C in the different experimental systems showed that H225C is exposed to the periplasmic face of the membrane.


EXPERIMENTAL PROCEDURES

Bacterial Strains and Culture Conditions

EP432 is an E. coli K12 derivative, which is melBLid, Delta nhaA1::kan, Delta nhaB1::cat, Delta lacZY, thr1 (11). TA16 is nhaA+nhaB+lacIQ and otherwise isogenic to EP432 (12). DH5alpha (U.S. Biochemical Corp.) was used as a host for construction of plasmids. Cells were grown either in L broth (LB) or in modified L broth (LBK) in which NaCl was replaced by KCl ((7) 87 mM, pH 7.5). Where indicated, the medium was buffered with 50 mM BTP, and pH was titrated with HCl. Cells were also grown in minimal medium A without sodium citrate (23). Thiamine (2.5 µg/ml) was added to all minimal media. When required, threonine (0.1 mg/ml) was added. For plates, 1.6% agar was used. Antibiotics were 100 µg/ml ampicillin and/or 50 µg/ml kanamycin and/or 12 µg/ml chloramphenicol. Resistance to Li+ and Na+ was tested as described previously (15).

Plasmids

All plasmids are pBR322 derivatives. pGM36 carries wild-type nhaA (24). Plasmids encoding His-tagged antiporters are pET20b (Novagen) derivatives as described below. pEP3T is a plasmid overproducing nhaA (12).

Site-directed Mutagenesis of Cysteines of NhaA and Construction of C-less NhaA and C-less H225C NhaA

Site-directed Cys replacements by serine, C200S, C308S, and C335S (Fig. 1), were obtained following a polymerase chain reaction-based protocol (25). DNA of pGM36 was utilized as the template. The end primers and the mutagenic primers are described in Table I. In all cases, the resulting mutagenized DNA (2050 bp) was digested with BglII-MluI, yielding a fragment of 682 bp containing each of the mutations (Fig. 1), which was ligated to the 6.2-kb BglII-MluI fragment of pGM36, to yield plasmid pC201S, pC309S, and pC335S. In each case, the entire fragment originated by polymerase chain reaction and placed in the recombinant plasmid was sequenced through the ligation junctions to verify the accuracy of mutagenesis (Table I). This routine ensured that the entire nhaA gene did not harbor mutations with the exception of the changes described.


Fig. 1. Restriction map of plasmid pYG10 that encodes His-tagged NhaA. This plasmid is a derivative of pEP3T (12) and pET20b(+) (Novagen, Madison, WI). The figure also shows the locations of the cysteine (C200S, C308S, and C335S) and histidine (H225C) mutations and the C terminus of the His-tagged NhaA.
[View Larger Version of this Image (11K GIF file)]


Table I.

Primers used for constructing the Cys-mutations in nhaA

Numbers in parentheses are related to the nhaA initiation codon.
Mutation Mutagenic primera Locationb Codon change observed

C200S TATTGAATCTGTCTGGTGCACGCCG 693-717 TGT right-arrow TCT
(586-610)
C308S TTAGTCTGTTCAGCTGGTTGGCGCT 1017-1041 TGC right-arrow AGC
(910-934)
C335S TGGGGATCCTGTCCGGTATCGGTTT 1098-1122 TGC right-arrow TCC
(991-1015)
H225C ATCGGGGGTTTGCGCAACTCT 769-792 CAC right-arrow TGC
(662-685)
End primer ATCGCTCTCTTTAACCCA  -318-300c None
(-425-407)
End primer CAGCATTTCGTGGGTGGATTCGAA 1706-1740d None
            GCAGCGAAGAT (1599-1633)

a  The mutated codons are shown in boldface.
b  Location numbers are on the sequence as appeared in GenBank access number J03879[GenBank].
c  This primer is upstream to the sequence of nhaA and can be found in access number X17311[GenBank], complementary to 237-217.
d  This primer is downstream to the sequence of nhaA and can be found in access number L24072[GenBank] complementary to 408-374.

For construction of C-less NhaA, pC200S and pC335S were digested with BamHI and the BamHI-BamHI fragments; 1.9 kb of the former and 5 kb of the latter were ligated to yield plasmid pC201S-C335S. This plasmid was then used as a template to introduce C308S as above, and pC-less nhaA (C200S, C335S and C308S) was obtained. The last mutation introduced a PvuII site.

For construction of C-less H225C, we used DNA of pC-less as a template and the end and mutagenic primers as described in Table I. The BglII-MluI fragment containing the mutation was cloned instead of BglII-MluI of pGM36.

Construction of His-tagged NhaA Derivatives

To construct a plasmid overproducing His-tagged NhaA we used pEP3T (12) and amplified by polymerase chain reaction a fragment (1.5 kb) using two mutagenic end primers (CTAGTCTAGAGGATCCGGAGCTTAT) and (TTTTCCTTTTGCGGCCGCAACTGATGGACGCAAACGA) introducing XbaI in the 5' and NotI in the 3' ends. The fragment was cloned into TA vector (Invitrogen, San Diego, CA), and the XbaI-NotI fragment of the recombinant plasmid was cloned into XbaI-NotI fragment (3.6 kb) of modified pET20b (Novagen, Madison, WI). The latter plasmid contains between NotI and XhoI sequences encoding two factor Xa cleavage sites in frame with the sequences encoding the 6 histidines. The resulting recombinant plasmid, designated pYG10 (Fig. 1), encodes for NhaA fused in frame in its C terminus to the two factor Xa cleavage sites followed by 6 histidines. To construct His-tagged derivatives of the C-less NhaA and C-less H225C the NheI-MluI (880 bp) fragment of pC-less or pC-less-H225C was cloned into NheI-MluI (4.2 kb) of pYG10 yielding plasmid His-tag C-less and His-tag C-less-H225C, respectively. All constructs were verified by sequencing using the Sequenase kit (Version 2.0, U. S. Biochemical Corp.).

Isolation of Everted Membrane Vesicles, Assay of Na+/H+ Antiporter Activity, and Quantitation of NhaA in the Membranes

Assays of Na+/H+ antiport activity were conducted on everted membrane vesicles (26). The assay of antiport activity was based upon the measurement of Na+ (or Li+) induced changes in the Delta pH as described (5, 27). NhaA in everted membrane vesicles (1 mg) was quantitated by Western analysis as described previously (15). Protein was determined according to Bradford (28).

Isolation of His-tagged Antiporters

The procedure was performed at 4 °C. Everted membrane vesicles (100-300 µg protein) were suspended in 1.15 ml containing 60 mM choline chloride, 4.5 mM Tris-Cl, pH.8, 110 mM sucrose, 20% glycerol, 100 mM MOPS, pH 7, and 1% DM. The suspension was gently mixed for 20 min and then centrifuged (Beckman model TLA100, 245,000 × g, 20 min). The supernatant was mixed with 90 µl of prewashed resin (Ni2+-NTA-agarose, Qiagen, Hilden, Germany). Prewashing was performed by cycles of resuspension and centrifugation (20,000 × g, 2 min); the first prewash was in 500 µl of H20, and the second was in binding buffer (modified Qiagen protocol: 5 mM imidazole, pH 7.9, 500 mM NaCl, 20 mM Tris-Cl, pH 7.9, 0.1% DM). For loading of the resin with His-tagged NhaA the mixture was incubated for 1 h with gentle mixing and then centrifuged.

The loaded resin was resuspended in 500 µl of binding buffer, mixed for 10 min, centrifuged, and washed again in wash buffer (30 mM imidazole, 500 mM NaCl, 20 mM Tris-Cl, pH 7.9, 0.02% DM, 10% glycerol). For elution the washed loaded resin was resuspended in 90 µl of elution buffer (300 mM imidazole, 500 mM NaCl, 20 mM Tris-Cl, pH 7.9, 0.02% DM, 10% glycerol) and incubated for 10 min as above. The supernatant devoid of the resin was collected by two consecutive centrifugations. The proteins in the supernatant were precipitated in 10% trichloroacetic acid for 30 min and collected by centrifugation (20,000 × g, 15 min), resuspended in sample buffer, and resolved by SDS-PAGE (29).

Treatment with NEM

Everted membrane vesicles were treated with NEM in 50 µl of reaction mixture containing, in final concentrations, membrane vesicles (100 µg protein), 100 mM potassium phosphate (at the indicated pH), 10 mM MgS04, and 1 mM NEM. The reaction (28 °C, 20 min) was stopped by addition of 20 mM dithiothreitol. Antiporter activity was assayed as described above using K-ATP instead of D-lactate to establish Delta pH since NEM inactivates electron transport. If not otherwise indicated for treatment with [14C]NEM, membrane vesicles (100-300 µg of protein) were resuspended in 500 µl of solution, pH 7.5, and incubated as above in the presence of 25 µM [14C]NEM (DuPont NEN, 40 mCi/mmol). Solubilization and purification of His-tagged NhaA protein was as above.


RESULTS AND DISCUSSION

Replacement Mutations of the Cysteines of NhaA

NhaA, the Na+/H+ antiporter of E. coli, has three cysteinyl residues (Fig. 1). To study the role of the cysteinyl residues in the activity of the antiporter, we replaced each cysteine of NhaA separately to obtain mutations encoding serine instead of cysteine 200 (C200S), 308 (C308S), or 335 (C335S). In addition, both a cysteine-less (C-less) nhaA was constructed with all cysteine residues replaced by serines, as well as C-less with a Cys replacement of His-225 (C-less H225C).

Growth Phenotype and NhaA Expression of the Cysteine Replacement Mutants

To study the growth phenotype of the mutants, each mutated plasmid was introduced into a strain lacking both antiporters NhaA and NhaB (EP432) (11). This strain does not have Na+/H+ activity and thus is highly sensitive to Na+ but regains antiporter activity and becomes resistant to the ion upon transformation with multicopy plasmid bearing wild-type nhaA. It was therefore found most suitable to explore plasmidic antiporter mutations with respect to the capacity to confer Na+ resistance and antiporter activity (30). The results of the growth experiments show that at pH 7.5 in the presence of up to 0.7 M NaCl, the growth rate of all cysteine mutants was very similar to that of the wild-type (75-85 min doubling time). Also at pH 8.5 in the presence of 0.6 M NaCl, all mutants grew, but C200S, C-less, and the C-less H225C mutants were slightly slower (doubling time of 95, 90, and 95 min, respectively) compared with the wild-type and the other cysteine mutants (doubling time of 75 min). There was no significant difference in colony formation of the various strains on agar plates.

The level of the NhaA-Cys mutated proteins in the membranes was determined immunologically using polyclonal antibody produced against the C terminus of NhaA (15). The mutants C308S, C-less, and C-less-H225C were expressed at a level similar to that of the wild-type protein. The level of C335S and C200S in the membrane was 60 and 30% that of the wild-type, respectively.

Na+/H+ Exchange Activity in Everted Membrane Vesicles

To determine whether any of the mutations affect antiporter activity, we isolated everted membrane vesicles from EP432 transformed with each of the mutant plasmids and assayed the specific Na+/H+ antiporter activity of these membranes as a function of pH. Again this host proves very useful since it has no background Na+/H+ antiporter activity when transformed with the vector plasmid (pBR322, Fig. 2A). The data obtained from the mutants at pH 8.5 are shown in Fig. 2A, and the pH profile of the Na+/H+ antiporter activity throughout the pH range from 7 to 8.5 is summarized in Fig. 2B. For comparison, the Na+/H+ antiporter activity versus pH of wild-type plasmid transformants is also shown.


Fig. 2. Na+/H+ antiporter activity in everted membrane vesicles of the NhaA-Cys mutants. Everted membrane vesicles were prepared from a Delta nhaADelta nhaB E. coli strain, EP432 (11), transformed with the indicated plasmids grown in LBK (pH 7.5). The plasmids were pGM36 bearing wild-type nhaA (24), pBR322, or plasmids carrying the various mutations in nhaA in which either C200, C308, or C335 or all cysteines were replaced with serine (plasmids pC200S, pC308S, pC335S, and pC-less, respectively). The Delta pH was monitored with acridine orange in medium containing 140 mM KCl, 10 mM Tricine, pH 8.5, 5 mM MgCl2, acridine orange (0.5 µM), and membrane vesicles (50-100 µg of protein). At the onset of the experiment Tris D-lactate (2 mM) was added (down-arrow ) and the fluorescence quenching (Q) was recorded until a steady state level of Delta pH (100% quenching) has been reached. NaCl (10 mM, ) was then added, and the new steady state of fluorescence obtained (dequenching) after each addition was monitored. A, the full trace is shown only for the control (pGM36). The other traces begin after the first steady state level has been reached. B, pH dependence of the Na+/H+ antiporter activity of the NhaA-Cys mutants. The medium pH was obtained by titration with either Tris or HCl. The percent of dequenching observed following addition of 10 mM NaCl is shown versus pH of the assay. black-square, EP432/pGM36 (wild-type); bullet , EP432/pC200S; black-triangle, EP432/pC308S; black-down-triangle , EP432/pC335S; square , EP432/pC-less; diamond , EP432/pC-less H225C. The experiments were repeated twice, and the results were essentially identical.
[View Larger Version of this Image (14K GIF file)]


The Na+/H+ antiporter activity of the C308S mutant is very similar to that of the wild-type NhaA both in maximal activity and pH sensitivity. Below pH 8 C335S and C200S show similar activity which is between 40 and 50% that of the wild-type. Above pH 8, whereas C335S reaches the steady state level of the wild-type, C200S remains at 60%.

The activity of the C-less mutant of NhaA is very similar to C200S and reaches a steady state level of about 60% of the wild-type at alkaline pH (Fig. 2, A and B). Thus, it is apparent that replacement of all three Cys residues, whether each separately or all together, in the same antiporter molecule does not markedly impair the antiporter activity, implying that neither of the cysteinyl residues of NhaA are mandatory to the Na+/H+ antiporter activity of NhaA.

It is obvious that high resolution structure of the transporter is required to determine the role of any residue in the mechanism. Nevertheless, it has recently become apparent (31, 32) that functional Cys replacements in transporters can be very useful since they allow site-specific labeling of the protein, at the reactive SH groups, with probes that can examine various aspects of structure and function relationship of the protein (Cys scanning). A principal difficulty with this general approach, however, is the complexity resulting from the presence of multiple cysteinyl residues in most proteins, three in the case of the NhaA antiporter. Thus, in addition to the important conclusion reached in this paper that cysteinyl residues do not play a critical role in the mechanism of the Na+/H+ antiport, the construction of a functional antiporter, devoid of cysteinyl residues, provides the basis for Cys-scanning analysis of NhaA.

Since His-225 has been shown to play an important role in the pH response of NhaA, we have replaced His-225 of the C-less antiporter with Cys. The Na+/H+ antiporter activity of Cless H225C at pH 8.5 in everted membrane vesicles was about 60% that of the C-less antiporter and 30-40% that of the wild-type (Figs. 3 and 2B). Most interestingly, the pH profile of C-less H225C was similar to the wild-type or the C-less NhaA (Fig. 2B). Taken together these results show that C-less H225C NhaA antiporter although at a decreased level is still functional and exhibits a pH dependence similar to that of wild-type and the C-less antiporter. These results are consistent with our previous data (16) showing that an antiporter harboring an H225C mutation in otherwise wild-type antiporter is similar to the latter both in activity and pH sensitivity. The C-less H225C mutant thus affords the possibility to test the effect of SH reagents at position 225 of NhaA.


Fig. 3. NEM inactivates C-less H225C but has no effect on wild-type or C-less NhaA. Everted membrane vesicles from EP432/pC-less or EP432/pC-less H225C were treated with NEM at pH 7.5, and the antiporter activity was assayed as described in the legend to Fig. 2B. Treatment was also conducted at the indicated pH values; treated and untreated membrane were compared, and the percent of inhibition of activity caused by NEM is shown. The experiment was repeated three times, and the results were essentially identical.
[View Larger Version of this Image (13K GIF file)]


While NEM Has No Effect on Wild-type or C-less NhaA It Inactivates Both H225C and C-less H225C

In accordance with previous results (17), the Na+/H+ antiporter activity of the wild-type NhaA protein, like the C-less antiporter, was not affected by treatment of the membranes with NEM (up to 2 mM) (Fig. 3). However, NEM (at 0.5 mM) inhibited, significantly, the C-less H225C antiporter (Fig. 3A). The most significant effect was obtained when the NEM treatment was conducted at pH 7.5 (Fig. 3B). The maximal inhibition (60-70%) was not increased with further increase of the NEM concentration. The presence of Na+ had no effect on the degree of NEM inhibition. Similar results (not shown) were obtained with NhaA mutant which harbors H225C in an otherwise wild-type protein (H225C). Interestingly, the residual activity of the NEM-inactivated C-less H225C is not sensitive to pH (not shown). Taken together these results emphasize again the importance of His-225 in the unique response of NhaA to pH (15, 16).

H225C Is Exposed to Alkylation by [14C]NEM Much More Readily Than the Native Cysteinyl Residues of NhaA

The observation that NEM significantly affects the NhaA antiporter, harboring instead of histidyl a cysteinyl residue at position 225, but has no effect on a wild-type antiporter with its three cysteines (C200, C308, C335), raised two alternatives: a modification of the cysteinyl residues by NEM has no inhibitory effects on the antiporter activity, and the Cys residues, which are in putative transmembrane segment (15), are not accessible to NEM.

To test whether the NhaA cysteinyl residues are NEM-accessible, we constructed His-tagged NhaA (Fig. 1) (and in addition His-tagged C-less and His-tagged C-less H225C). Plasmidic His-tagged NhaA was as effective as plasmidic wild-type antiporter in conferring Na+ resistance upon Delta nhaADelta nhaB and in promoting Na+/H+ antiporter activity in isolated membrane vesicles (not shown). The pH sensitivity of the His-tagged NhaA was also similar to that of the wild-type antiporter. The His-tagged NhaA readily bound onto the Ni+2 resin (Fig. 4A). Out of the many membrane proteins (Fig. 4A, lane 2) exposed to the resin many did not bind (Fig. 4A, lane 3) or were eluted by the washes at low imidazole concentrations (<= 30 mM, Fig. 4A, lanes 4 and 5). At 300 mM imidazole the His-tagged NhaA was eluted as a prominent band at 30 kDa (Fig. 4, lane 6). As expected from its longer C terminus His-tagged NhaA was slightly heavier than the native NhaA (Fig. 4A, lane 7). The two additional very weak bands of 51 and 83 kDa shown are most probably aggregates of the antiporter, a property noted before for this protein (12).


Fig. 4. H225C is exposed to alkylation by [14C]NEM much more than the native cysteinyl residues of NhaA. Everted membrane vesicles of TA16 cells transformed with plasmids harboring various His-tagged antiporters: His-tagged wild-type, His-tagged C-less, and His-tagged C-less H225C were reacted with [14C]NEM and solubilized by 1% DM. The soluble fraction was reacted with Ni-NTA resin to isolate the His-tagged antiporters. A shows the proteins in the various purification steps resolved on SDS-PAGE. Lane 1, molecular mass markers in kDa; lane 2, total solubilized membrane fraction, loaded the Ni+2 resin; lane 3, proteins that do not bind to the resin and remain in the supernatant after centrifugation of the loaded resin suspension (20,000 × g, 2 min, 26 °C); lane 4, proteins eluted from the resin by the binding buffer wash (5 mM imidazole); lane 5, proteins eluted by the wash containing 30 mM imidazole; lane 6, His-tagged NhaA eluted in the presence of 300 mM imidazole; lane 7, wild-type NhaA. B shows the autoradiogram of purified His-tagged proteins: lane 1, C-less H225C; lane 2, C-less; lane 3, wild-type. The results shown are from one representative experiment out of eight.
[View Larger Version of this Image (56K GIF file)]


This rapid isolation of the His-tagged NhaA formed the basis for an assay designed to probe in situ the reactivity of the NhaA Cys residues to NEM as well as to other SH reagents. In this assay everted membrane vesicles were treated with [14C]NEM, and the His-tagged NhaA derivatives were isolated on the Ni+2 resin and subjected to autoradiography (Fig. 4B) to estimate the number of NEM titratable molecules per purified NhaA protein.

These results show that when the [14C]NEM treatment was conducted at a concentration of 25 µM, His-tagged C-less H225C (Fig. 4B, lane 1) was labeled to a level at least 10-fold higher than the His-tagged wild-type antiporter (Fig. 4B, lane 3), in spite of the three cysteines of the latter. As expected there was no labeling of the His-tagged C-less NhaA (Fig. 4B, lane 2).

The concentration dependence of the alkylation by [14C]NEM was determined with His-tagged C-less H225C (Fig. 5). The results show that at 0.5 mM NEM saturation of the alkylation reaction was reached. To estimate the maximal number of [14C]NEM molecules bound per purified His-tagged C-less H225C NhaA molecule, the amount of the radioactivity bound to the antiporter at 0.5 mM NEM was also determined directly by scintillation counting of the purified antiporter fraction. A NEM/NhaA mol ratio of 1.02 was calculated from the amount of radioactivity, specific activity of [14C]NEM, and the amount of the pure protein in the fraction, suggesting a NEM/NhaA stoichiometry of 1. A similar stoichiometry was found with RSO membrane vesicles. At this NEM concentration maximal inhibition (at pH 7.5) of the Na+/H+ antiporter activity was observed in everted membrane vesicles isolated from C-less H225C cells (Fig. 3).


Fig. 5. Concentration dependence of alkylation by [14C]NEM of His-tagged C-less H225C and His-tagged wild-type NhaA. Everted membrane vesicles isolated from TA16 transformed with His-tagged C-less-H225C (bullet ) or plasmid pYG10 (His-tagged wild-type (w.t.)) (black-square) were reacted with [14C]NEM at the indicated concentrations. The antiporters were affinity purified as described in Fig. 4A and autoradiographed. The radioactivity was scanned by the Bio-Imaging Analyzer (Model Bas 1000, FUJIX, Japan) equipped with MacBas software (FUJI Photo Film, Co. V.2.2) and expressed as photo-stimulated luminescence units after normalization according to the specific activity and the concentration of the purified antiporter. The error bars are shown.
[View Larger Version of this Image (22K GIF file)]


The effect of NEM concentration on the alkylation of the native cysteines of the wild-type NhaA was also determined (Fig. 5). It was observed that up to 0.5 mM the alkylation was very low but increased with increasing concentrations. However, even at 2 mM [14C]NEM there was no saturation of the reaction. It is concluded that H225C is much more exposed to NEM than the native NhaA cysteines.

The fact that H225C is much more exposed to NEM as compared with the native Cys residues of NhaA is intriguing. Since H225C in right-side out membranes has been found as reactive to NEM as in everted membrane vesicles, it is suggested that neither membrane permeability nor the topology of H225C with respect to the face of the membrane is the cause for the preferential reactivity of H225C. Since the native cysteines are located in putative alpha helices while H225C is supposed to reside at the membrane surface (15), a tempting explanation is that His-225 is exposed to the aqueous phase of the membrane, a property which readily exposes it to NEM. On the other hand, the residues embedded in the transmembrane domains of the protein are masked from the reagent. Permeation of NEM into the protein thus appears the main factor determining the NEM reactivity of the cysteinyl residues. Hence NEM reactivity may bear upon different domains of membrane proteins. Probing Cys replacements of the TetB protein has recently led to similar conclusions.2

The Membrane Topology of H225C

The cross-membrane topology of H225C was investigated by probing in situ the accessibility of H225C to membrane-impermeant SH reagents both in oriented membrane preparation, ISO, or RSO as well as intact cells. Accessibility to the probe implied that H225C is located at or near the face of the membrane exposed to the side of application of the impermeant probe. Inaccessibility of the H225C residue to the impermeant probe but accessibility to a permeant probe in membranes of the reversed orientation served as powerful internal controls in these experiments.

In the protocol devised to determine the reactivity of His-tag C-less H225C to SH reagents, cells or membrane vesicles were first treated with the membrane-impermeant reagent, washed, and subsequently exhaustively alkylated by [14C]NEM. The level of the alkylation was determined by autoradiography of the affinity purified antiporter (Ni+2 resin) separated on SDS-PAGE. As shown above (Fig. 5), in untreated membranes the alkyl/NhaA stoichiometry was close to one whether right-side out or everted membrane vesicles were used. In addition, C-less NhaA was not labeled under the conditions employed (Fig. 4B). Both these controls implied that alkylation by [14C]NEM can be used to titrate the number of reactive H225C residues in NhaA. Therefore the difference between the number of NEM alkylatable H225C before and after exposure to the -SH reagent of selective permeability allowed us to estimate the reactivity of H225C to this reagent.

Small, charged and highly water-soluble sulfhydryl-specific reagents derived from methanethiosulfonate (MTS) have previously been used to probe the cross-membrane topology of cysteines strategically placed in the acetylcholine receptor (19, 20). These include the positively charged MTSEA and MTSET, both considered membrane-impermeant (20, 33).

A typical experiment is shown in Fig. 6A using MTSEA. Surprisingly, treatment with MTSEA for 1 min whether applied to right-side out or inside-out membrane vesicles reduced completely the number of NEM-titratable H225C residues. These results could be interpreted in two ways, either MTSEA is permeant in the E. coli membrane and modifies H225C from both sides of the membrane or H225C is accessible from both sides of the membrane. However, we cannot exclude the existence of a carrier-mediated transport of MTSEA across the membrane. Furthermore, since MTSEA is a weak base with a pK of around 8.5,3 it is possible that it equilibrates across the membrane in its undissociated form similar to other weak amines of similar pK (35, 36). We therefore probed H225C with additional SH reagents suggested to be impermeant to membranes.


Fig. 6. NhaA H225C is exposed to MTSET in RSO membrane vesicles but is accessible to MTSEA in both RSO and ISO membrane vesicles. RSO or ISO membrane vesicles (200 µg of protein) isolated from cells expressing His-tagged C-less H225C NhaA were resuspended in 250 µl containing 100 mM KPi (pH 7.5) and 10 mM MgSO4. A, at zero time MTSEA (2.5 mM) was added, and the membranes were either washed immediately (lanes 2 and 4) or incubated for 1 min at room temperature and then washed (lanes 1 and 3). For titration of free H225C residues left all washed samples were exposed to [14C]NEM (25 µM, 40 mCi/mmol) for 20 min at room temperature; the His-tagged C-less H225C NhaA was affinity purified, run on SDS-PAGE, and autoradiographed. For quantitation of the radioactivity in the protein, the autoradiograms were scanned and the intensities expressed in % (100% = the density observed at zero time for each respective treatment). Both the autoradiograms and the results of scanning are shown. B, RSO (lanes 1-3) or ISO (lanes 4-6) membrane vesicles (200 µg protein) were treated with MTSET (1 mM) for 0 min (lanes 1 and 4), 5 min (lanes 2 and 5), or 20 min (lanes 3 and 6), washed, and assayed for NEM-reactive residues in NhaA as described in A. The error range is as in Fig. 5.
[View Larger Version of this Image (46K GIF file)]


The results obtained by similar protocol conducted with MTSET are summarized in Fig. 6B. A clear difference in the number of NEM-titrable residues was observed between NhaA isolated from RSO- or ISO-treated membrane vesicles; only 4% of the NEM-titrable residues of H225C remained in RSO membrane vesicles following 20 min treatment as compared with 44% in treated ISO membranes. Further incubation had no significant additional effect. Hence after 20 min of treatment the number of NEM-titratable H225C in RSO as compared with ISO vesicles were 8-10-fold lower. This result suggests that H225C is much more exposed to modification by MTSET in RSO vesicles as compared with ISO vesicles.

PCMB and its sulfonic acid derivative, PCMBS, are organomercurials that share chemical specificity for the reaction with cysteines. They differ, however, in several properties. PCMB is lipid-soluble weak acid which when protonated (pK 4) has access to cysteine residues at both membrane surfaces. On the other hand, in PCMBS the strongly acidic sulfonic acid group (pK 1.5) is very soluble in water and is largely membrane-impermeant, which attacks those cysteines exposed to the medium. Therefore a comparison of the response to PCMB and PCMBS could, in principle, give important information concerning the location of reactive cysteines as shown most elegantly with UhpT transporter (22).

Fig. 7 shows the results obtained with PCMB and PCMBS with both RSO and ISO membrane vesicles. In both membrane types PCMB reduced dramatically the titratable NEM residues as expected for membrane-permeable SH reagent (Fig. 7, lanes 2 and 6). On the other hand, only in RSO membrane vesicles PCMBS had a pronounced effect, reducing by 10-15-fold the NEM-titratable residues (compare lanes 8 to 4 in Fig. 7). In the ISO vesicles only a 2-fold decrease was observed (Fig. 7, lane 4). These results show that H225C is significantly more exposed to PCMBS in RSO than in ISO vesicles.


Fig. 7. Whereas PCMB reacts with NhaA H225C both in RSO and ISO membrane vesicles PCMBS reacts only in RSO. ISO (lanes 1-4), RSO (lanes 5-8) membrane vesicles (200 µg), or intact cells (5 ml, A600 = 0, 7) were treated with 0.2 mM of either PCMB (lanes 1, 2, 5, and 6) or PCMBS (lanes 3, 4, 7, 8, and 10) or 2 mM PCMBS (lane 11) for 0 min (lanes 1, 3, 5, 7, and 9) or 10 min (lanes 2, 4, 6, 8, 10, and 11). ISO membrane vesicles were isolated from the washed treated cells. All membranes were washed and assayed for NEM-titratable residues as described in Fig. 6. ISO membrane vesicles were isolated from the washed treated and also assayed for NEM-titratable residues. The autoradiograms are shown. In addition, the amount of NEM-titratable H225C residues was estimated from the densitometry of the autoradiograms and expressed as %. 100% = the density observed at zero time. The error range is as in Fig. 5.
[View Larger Version of this Image (48K GIF file)]


It is not clear why some reactivity with PCMBS was observed in ISO membrane vesicles. One possibility is that some heterogeneity exists in this membrane preparation with respect to orientation. This, however, is unlikely since these membrane preparations have been shown to be very homogenous consisting of mainly everted membrane vesicles (26, 36). Another alternative that can be considered is that the membranes are slightly permeable to PCMBS either originally or due to the experimental manipulation.

The very different reactivity of H225C to the hydrophilic SH reagents (MTSET and PCMBS) in RSO and ISO membrane vesicles and similar high accessibility to the hydrophobic SH reagents (MTSEA and PCMB) in both membrane types suggest that H225C is located at or near the periplasmic face of the membrane.

Given this conclusion it was expected that PCMBS would be able to react with H225C of NhaA even in intact cells. For this experiment intact cells were exposed to PCMBS and then after extensive washing of the reagent ISO membrane vesicles were isolated and exposed to [14C]NEM for titrating the free H225C residues. Indeed, in intact cells PCMBS blocked completely the H225C residues leaving no NEM-titratable residues in NhaA (Fig. 7, lanes 9-11).

Based on the hydropathic analysis of the predicted protein sequence of NhaA we have previously published a putative secondary structure model with 11 hydrophobic TMS connected with hydrophilic loops (12, 15). In this model H225C was predicted to be located in the loop connecting TMS VII and VIII at the edge of TMS 7. However, a careful study of the topology of NhaA using phoA fusions showed that NhaA consists of 12 TMS, and in this model H225C is located at the edge of TMS 8 facing the periplasmic face of the membrane (37). In line with this model the C terminus was found exposed to the cytoplasm. The results obtained in the present work showing directly that H225C is exposed at the periplasmic face of the membrane strengthens the new 12 TMS model of NhaA.

The periplasmic topology of H225C found in the present work supports the contention that the "pH sensor" of NhaA interacts indirectly with His-225 (30). In ISO membrane vesicles H225C faces the lumen of the vesicles. Since these membrane vesicles pump protons in, their intravesicular space becomes very acidic during respiration. This acid pH is expected to totally inhibit the antiporter (12). However, although H225C is exposed to this acidic space in ISO vesicles, the antiporter is active under these conditions. Hence, although we know that His-225 affects the pH sensitivity of NhaA, as yet we do not know which residue directly senses pH and how this signal is transduced by the NhaA protein.


FOOTNOTES

*   This work was supported by a grant from the Binational Science Foundation (to E. P.) and the Massimo and Adelina Della Pergolla Chair in Life Sciences (awarded to E. P.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    An incumbent of the Alberman Fellowship.
§   An incumbent of the Moshe Shilo Center for Marine Biogeochemistry.
   To whom correspondence should be addressed. Tel.: 972-2-6585094; Fax: 972-2-5634625.
1    The abbreviations used are: NEM, N-ethylmaleimide; BTP, 1.3 bis[tris(hydroxymethyl)-methylamino]propane; DM, n-dodecyl beta -D-maltoside; MOPS, (3-[N-morpholino]propane sulfonic acid); PCMB, p-chloromercuribenzoic acid; PCMBS, p-chloromercuribenzosulfonate; MTSEA, methanethiosulfonate ethylammonium; MTSET, methanethiosulfonate ethyl-trimethyl ammonium bromide; RSO, right-side-out membrane vesicles; ISO, inside-out membrane vesicles; TMS, trans-membrane segment; bp, base pair(s); kb, kilobase pair(s); PAGE, polyacrylamide gel electrophoresis; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] glycine.
2    A. Yamaguchi, personal communication.
3    M. Akabas, personal communication.

REFERENCES

  1. Padan, E., and Schuldiner, S. (1992) in Alkali Cation Transport Systems in Procaryotes (Bakker, E., ed), pp. 3-24, CRC Press, Inc., Boca Raton, FL
  2. Padan, E., and Schuldiner, S. (1993) J. Bioenerg. Biomembr. 25, 647-669 [Medline] [Order article via Infotrieve]
  3. Padan, E., and Schuldiner, S. (1994) Biochim. Biophys. Acta 1185, 129-151 [Medline] [Order article via Infotrieve]
  4. Schuldiner, S., and Padan, E. (1992) in Alkali Cation Transport Systems in Procaryotes (Bakker, E., ed), pp. 25-51, CRC Press, Inc., Boca Raton, FL
  5. Goldberg, B. G., Arbel, T., Chen, J., Karpel, R., Mackie, G. A., Schuldiner, S., and Padan, E. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2615-2619 [Abstract]
  6. Pinner, E., Padan, E., and Schuldiner, S. (1992) J. Biol. Chem. 267, 11064-11068 [Abstract/Free Full Text]
  7. Padan, E., Maisler, N., Taglicht, D., Karpel, R., and Schuldiner, S. (1989) J. Biol. Chem. 264, 20297-20302 [Abstract/Free Full Text]
  8. Karpel, R., Alon, T., Glaser, G., Schuldiner, S., and Padan, E. (1991) J. Biol. Chem. 266, 21753-21759 [Abstract/Free Full Text]
  9. Rahav-Manor, O., Carmel, O., Karpel, R., Taglicht, D., Glaser, G., Schuldiner, S., and Padan, E. (1992) J. Biol. Chem. 267, 10433-10438 [Abstract/Free Full Text]
  10. Carmel, O., Dover, N., Rahav-Manor, O., Dibrov, P., Kirsch, D., Karpel, R., Schuldiner, S., and Padan, E. (1994) EMBO J. 13, 1981-1989 [Abstract]
  11. Pinner, E., Kotler, Y., Padan, E., and Schuldiner, S. (1993) J. Biol. Chem. 268, 1729-1734 [Abstract/Free Full Text]
  12. Taglicht, D., Padan, E., and Schuldiner, S. (1991) J. Biol. Chem. 266, 11289-11294 [Abstract/Free Full Text]
  13. Pinner, E., Padan, E., and Schuldiner, S. (1994) J. Biol. Chem. 269, 26274-26279 [Abstract/Free Full Text]
  14. Taglicht, D., Padan, E., and Schuldiner, S. (1993) J. Biol. Chem. 268, 5382-5387 [Abstract/Free Full Text]
  15. Gerchman, Y., Olami, Y., Rimon, A., Taglicht, D., Schuldiner, S., and Padan, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1212-1216 [Abstract]
  16. Rimon, A., Gerchman, Y., Olami, Y., Schuldiner, S., and Padan, E. (1995) J. Biol. Chem. 270, 26813-26817 [Abstract/Free Full Text]
  17. Damiano, E., Bassilana, M., and LeBlanc, G. (1985) Eur. J. Biochem. 148, 183-188 [Abstract]
  18. Altenbach, C., Marti, T., Khorana, H. G., and Hubbell, W. L. (1990) Science 248, 1088-1092 [Medline] [Order article via Infotrieve]
  19. Akabas, M. H., Stauffer, D. A., Xu, M., and Karlin, A. (1992) Science 258, 307-310 [Medline] [Order article via Infotrieve]
  20. Akabas, M. H., Kaufmann, C., Archdeacon, P., and Karlin, A. (1994) Neuron 13, 919-927 [Medline] [Order article via Infotrieve]
  21. Frillingos, S., and Kaback, H. R. (1996) Biochemistry 35, 3950-3956 [CrossRef][Medline] [Order article via Infotrieve]
  22. Yan, R. T., and Maloney, P. C. (1993) Cell 75, 37-44 [Medline] [Order article via Infotrieve]
  23. Davies, B. D., and Mingioli, E. S. (1950) J. Bacteriol. 60, 17-28
  24. Karpel, R., Olami, Y., Taglicht, D., Schuldiner, S., and Padan, E. (1988) J. Biol. Chem. 263, 10408-10414 [Abstract/Free Full Text]
  25. Ho, S. F., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst) 77, 51-59 [CrossRef][Medline] [Order article via Infotrieve]
  26. Rosen, B. P. (1986) Methods Enzymol. 125, 328-336 [Medline] [Order article via Infotrieve]
  27. Schuldiner, S., and Fishkes, H. (1978) Biochemistry 17, 706-711 [Medline] [Order article via Infotrieve]
  28. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  29. Schagger, H., and Von Jagow, G. (1987) Anal. Biochem. 166, 368-379 [Medline] [Order article via Infotrieve]
  30. Padan, E., and Schuldiner, S. (1996) in The Handbook of Biological Physics (Konings, W. N., Kaback, H. R., and Lolkema, J., eds), Vol. II, pp. 501-531, Elsevier Science Publishers B.V., Amsterdam
  31. Frillingos, S., and Kaback, H. R. (1996) Biochemistry 35, 5333-5338 [CrossRef][Medline] [Order article via Infotrieve]
  32. Wu, J., Frillingos, S., and Kaback, H. R. (1995) Biochemistry 34, 8257-8263 [Medline] [Order article via Infotrieve]
  33. Stauffer, D. A., and Karlin, A. (1994) Biochemistry 33, 6840-6849 [Medline] [Order article via Infotrieve]
  34. Deleted in proofDeleted in proof
  35. Rottenberg, H., Grunwald, T., and Avron, M. (1971) FEBS Lett. 13, 41-44 [CrossRef][Medline] [Order article via Infotrieve]
  36. Reenstra, W. W., Patel, L., Rottenberg, H., and Kaback, H. R. (1980) Biochemistry 19, 1-8 [Medline] [Order article via Infotrieve]
  37. Rothman, A., Padan, E., and Schuldiner, S. (1996) J. Biol. Chem. 271, 32288-32292 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.